Tirzepatide is approved under two brand names: Mounjaro for type 2 diabetes (FDA May 2022) and Zepbound for chronic weight management (November 2023) and moderate-to-severe obstructive sleep apnoea with obesity (December 2024) 28
Other people may make different choices according to their risk tolerance and need for quicker solutions to stave off or treat cognitive decline/dementia
Frequently asked questions Can I just take an oral B12 supplement with my regular semaglutide
Ongoing education, monitoring, and communication with your healthcare team are essential for managing side effects and achieving your health goals
In fact, while on "The Kelly Clarkson Show" in 2024, she claimed that one viewer thought she had been wearing a "fat suit" for a film appearance
Higher doses, longer treatment, and the presence of musculoskeletal pain before treatment began were also associated with greater lean body mass decline with both drugs, the researchers found